Filter News
Area of Research
- (-) Supercomputing (37)
- Advanced Manufacturing (3)
- Biological Systems (1)
- Biology and Environment (22)
- Clean Energy (55)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (2)
- Electricity and Smart Grid (3)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (1)
- Fusion and Fission (29)
- Fusion Energy (10)
- Isotope Development and Production (1)
- Isotopes (12)
- Materials (56)
- Materials for Computing (3)
- National Security (14)
- Neutron Science (26)
- Nuclear Science and Technology (39)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (1)
- Sensors and Controls (1)
News Topics
- (-) Biomedical (17)
- (-) Grid (5)
- (-) Nuclear Energy (4)
- (-) Physics (8)
- (-) Space Exploration (3)
- 3-D Printing/Advanced Manufacturing (5)
- Advanced Reactors (1)
- Artificial Intelligence (36)
- Big Data (20)
- Bioenergy (9)
- Biology (11)
- Biotechnology (2)
- Buildings (4)
- Chemical Sciences (5)
- Climate Change (17)
- Computer Science (95)
- Coronavirus (14)
- Critical Materials (3)
- Cybersecurity (8)
- Decarbonization (5)
- Energy Storage (8)
- Environment (21)
- Exascale Computing (24)
- Frontier (29)
- Fusion (1)
- High-Performance Computing (40)
- Isotopes (2)
- Machine Learning (14)
- Materials (15)
- Materials Science (16)
- Mathematics (1)
- Microscopy (7)
- Molten Salt (1)
- Nanotechnology (11)
- National Security (8)
- Net Zero (1)
- Neutron Science (13)
- Partnerships (1)
- Polymers (2)
- Quantum Computing (19)
- Quantum Science (24)
- Security (5)
- Simulation (15)
- Software (1)
- Summit (43)
- Sustainable Energy (10)
- Transportation (6)
Media Contacts
A study led by researchers at ORNL used the nation’s fastest supercomputer to close in on the answer to a central question of modern physics that could help conduct development of the next generation of energy technologies.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
To explore the inner workings of severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, researchers from ORNL developed a novel technique.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Since the 1930s, scientists have been using particle accelerators to gain insights into the structure of matter and the laws of physics that govern our world.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.
ORNL researchers have developed an intelligent power electronic inverter platform that can connect locally sited energy resources such as solar panels, energy storage and electric vehicles and smoothly interact with the utility power grid.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.